Aehr Test Reports Strong Revenue Growth Outlook Amid Market Volatility
Shares of Aehr Test (AEHR) surged over 27% following the company's guidance projecting a threefold revenue increase for fiscal year 2027, despite wider full-year losses in FY2026. The stock rebounded after hitting $75 earlier and was buoyed by strong Q4 performance with net income of $1.4 million.
Topics: ai_industry_impact revenue_growth_guidance stock_movement